. Author manuscript; available in PMC: 2010 Oct 15.

Published in final edited form as: Cancer. 2009 Oct 15;115(20):4795–4806. doi: 10.1002/cncr.24519

Table 1.

Formation of tumors in CB-17 SCID mice

Cell lines	Genotype	Injection site	Number of tumors/number of injections
MSC	hTERT^-, TAg^-, Ras^-	s.c.	0/8
MSC-T	hTERT⁺, TAg^-, Ras^-	s.c.	0/8
MSC-S	hTERT^-, TAg⁺, Ras^-	s.c.	0/8
MSC-TS	hTERT⁺, TAg⁺, Ras^-	s.c.	0/8
MSC-TSR6	hTERT⁺, TAg⁺, Ras⁺	s.c.	7/8
	hTERT⁺, TAg⁺, Ras⁺	tibia	4/4
MSC-TSR4	hTERT⁺, TAg⁺, Ras⁺	s.c.	6/8
	hTERT⁺, TAg⁺, Ras⁺	tibia	4/4

Abbreviation: s.c. subcutaneous